JPRN-UMIN000008342
Completed
未知
An open-label randomized controlled trial to assess the efficacy and safety of chronic hepatitis C and compensated cirrhosis patients with the prescribing pattern of vitaminD plus peginterferon alpha-2a /ribavirin. - The prescribing pattern of vitaminD plus peginterferon alfa-2a/ribavirin for treatment of chronic hepatitis C and compensated cirrhosis patients.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Chronic hepatitisC patients and compensated cirrhosis patients
- Sponsor
- Saitama Medical University
- Enrollment
- 80
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The following patients were excluded 1\)Women of childbearing potential and pregnancy, lactating woman 2\) allergic to ribavirin or nucleoside analogues 3\)an uncontrollable heart trouble (myocardial infarction, heart failure, or arrhythmia) 4\)hemoglobinopathy(thalassemia, sickle cell disease) 5\) severe renal disease, Ccr \<50ml/min 6\) severe depression or psychosomatic disorders 7\)severe liver disease 8\) autoimmune hepatitis or HBV 9\) drug allergy against interferon 10\) Allergic to vaccine or biological preparations 11\) Concomitant herbal medication of Sho\-saikoto 12\) history of interstitial pneumonia 13\) high\-dose lipid soluble vitamin agents using patients. 14\)Other conditions considered inappropriate by attending physician
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
An open-label randomized controlled trial to assess the efficacy and safety of chronic hepatitis C patients with vitaminD plus peginterferon alpha-2a /ribavirin.versus alfacalcidol plus peginterferon alpha-2a /ribavirin.Chronic hepatitis C patients with genotype 1 and high viral load (>= 5 Log IU/mL)JPRN-UMIN000004210Saitama Medical University40
Not yet recruiting
Not Applicable
A trial to assess the role of serial physical examination for well appearing babies at risk of sepsisCTRI/2024/04/066566ONE
Recruiting
Phase 2
Effect of cholestyramine on post-ESD ulcer healingJPRN-jRCTs031200235Tamura Shigeki100
Not yet recruiting
Phase 2
To study the effect of Bhunimbadi Vati and its add-on effect with Tablet Glimepiride Metformin in Madhumeha wsr to Type 2 Diabetes mellitusHealth Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2023/03/050496Dr Kiran Damoo Ubhe
Recruiting
Phase 2
Management of pelvic organ prolapse through AyurvedaCTRI/2023/09/057495Dr Salini P